(VIANEWS) – The NASDAQ ended the session with Inovio Pharmaceuticals rising 7.44% to $8.35 on Monday, following the last session’s upward trend. NASDAQ Composite rose 1.6% to $14,950.38, after two sequential sessions in a row of gains, on what was an all-around up trend exchanging session today.
Today’s last reported volume for Inovio Pharmaceuticals is 1969380, 60.63% below its average volume of 5002960.
Inovio Pharmaceuticals’s last close was $8.08, 57.47% below its 52-week high of $19.00.
Inovio Pharmaceuticals’s Sales
Inovio Pharmaceuticals’s sales growth is 2.2% for the ongoing quarter and 4688.1% for the next. The company’s growth estimates for the current quarter is 69.9% and a drop 318.2% for the next.
Inovio Pharmaceuticals’s Revenue
Year-on-year quarterly revenue growth declined by 72%, now sitting on 6.46M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,
Inovio Pharmaceuticals’s stock is considered to be overbought (>=80).
Inovio Pharmaceuticals’s Stock Yearly Top and Bottom Value
Inovio Pharmaceuticals’s stock is valued at $8.35 at 18:16 EST, way under its 52-week high of $19.00 and way higher than its 52-week low of $5.81.
Inovio Pharmaceuticals’s Moving Average
Inovio Pharmaceuticals’s worth is below its 50-day moving average of $8.54 and under its 200-day moving average of $9.12.
More news about Inovio Pharmaceuticals (INO).